Customer Testimonials

Discover the ProFound impact our AI technologies are making on our customers' facilities and patients

ProFound AI for Digital Breast TomosynthesisProFound AI
Risk
PowerLook Density Assessment

Expert insights today. ProFound performance tomorrow.

ProFound AI

Arnold B. Honick, MD,Diagnostic Radiology
Specialist at RCI
“When it comes to AI, iCAD was the first in the game. Although AI itself is still in its infancy, iCAD is ahead of other companies that are just now entering the market of breast AI. Additionally, the data supporting ProFound AI speaks for itself. After looking at reader studies for other AI solutions, we were not as confident that what they were offering was as robust as iCAD’s technology. Other AI solutions are essentially a black box attached to each gantry, and there is a significant cost per gantry. ProFound AI operates on just one centralized server, which streamlined and accelerated the integration process.”“We decided to adopt ProFound AI because we felt it was the best product available to provide valid CAD markers on DBT. We also found iCAD’s other breast AI solutions enticing, such as PowerLook® Density Assessment and ProFound AI® Risk, as technologies we would like to assess.”“ProFound AI has provided noticeable efficiency improvements for us already. It gives me the confidence that I’m looking at the appropriate slices, or images. And using the Case Scores, we are now able to help decipher mammograms with very low likelihood of containing an abnormality from one that might require further evaluation. I’ve learned to trust ProFound AI. We found a couple cases where ProFound AI helped the radiologist find a subtle area of distortion that might have been easily overlooked. And these are clearly abnormalities on the synthetic view that you would never see, so it has certainly helped improve our performance and accuracy as well.”
Elena Cauzza, MD,Radiologist at Radiomedica
& xDonna, a mammography and breast diagnosis center
“I was delighted with my collaboration with the intellimed team. They accompanied us throughout the process of upgrading to artificial intelligence, from the decision to choose iCAD’s breast AI solutions, such as ProFound AI, to their seamless integration into our daily workflow. As an imaging center specializing in women’s healthcare, knowledge and understanding of the space were essential to ensure the project was a success.”
Rafaële Baulieux Vautrin, MD
Radiologist Imapole (France)
“After using ProFound AI for about a month, we were sold. This leading-edge AI solution accurately identifies suspicious lesions and provides Certainty of Finding scores, which help to improve our team’s confidence in making clinical decisions. With results displayed conveniently on our reading station, ProFound AI acts as a real safety net, as it empowers our team to catch even the smallest and most difficult to detect lesions.”
Carolina Walter, MD Radiologist
Medimage (Switzerland)
“ProFound AI offers daily assistance to help me detect breast cancer more effectively and efficiently. It supports me in case assessment and improves my confidence, even while reading challenging cases, such as those with dense breasts.”
Joshua A. Nepute, MD, Radiologist, IU Health Frankfort, IU Health Arnett, IU Health White Memorial“For radiologists who may not have as much experience with DBT, ProFound AI is a great tool, as it can help ensure they’re being thorough and adequately going through every single image slice. For radiologists who have more experience with DBT, ProFound AI provides additional confirmation and clinical confidence to ensure we’re doing a good job for our patients.”“We saw our volume of mammography screenings decrease significantly during the pandemic however, since this past spring, our volume has skyrocketed. We are at least 10% above our pre-pandemic levels at this time, which has led to feelings of burnout by many of our radiologists, but ProFound AI has been a reliable backup for our team, as it helps to ensure we’re performing at an optimum level and calling back only those patients who need additional imaging.” Diana James, MD, PhD, Radiologist, Director of Breast Imaging at Jefferson Radiology, Hartford, CT"We began the implementation of ProFound AI at the end of 2019 and completed the rollout in the middle of the pandemic, in mid-2020. Just before that time, in mid-2019, we converted our practice to 100% tomosynthesis. We are typically a very high-volume practice reading more than 50,000 screening mammograms per year, and the addition of a ‘second reader’ via ProFound AI helped our radiologists absorb our increased workload. We paused our screening mammogram program per SBI recommendations during the beginning of the pandemic, but were quickly back to full plus volume by August 2020. ProFound AI helped us to read those cases quickly with the confidence that we were not missing cancers.”William G. Way Jr., MD,Diagnostic Radiologist
at Wake Radiology
“As a diagnostic radiologist, I’m not reading nearly as many mammograms as someone reading screening mammograms, but I have still grown to rely on the technology. I see a fair number of screening callbacks, and when I review the diagnostic images, I rely heavily on the areas of concern detected by ProFound AI on the original screening mammogram. When my findings at the time of the diagnostic workup are concordant with ProFound AI from the original screening examination, I feel much better about signing off on the case as a BIRADS 2 or 3. I have come to appreciate that when ProFound AI indicates the risk of malignancy is low, you can almost always trust it. And for my colleagues who do large volume screening mammography, ProFound AI serves as a reliable ‘second reader’ that helps them avoid making errors in interpretation.”
Angela Fried, MD,
Director of Breast Imaging, SimonMed Imaging
“After a year of using it, I’ve come to an eye-opening realization: ProFound AI is looking at things that we clinicians don’t necessarily recognize as signs of cancer. For example, the technology flagged a few cases last year that didn’t appear visibly as signs of cancer at the time, but when the patient returned this year, there’s definitely a cancer there. We’ve really gotten to trust it, and I am hoping that more of those subtle, obscured lesions will be picked up earlier because of this.”
Mark Traill, MD, University of Michigan Health-West“iCAD’s ProFound algorithm is very functional.  My MQSA numbers are the best they have ever been in my career in term of cancer detection and call back rate.  I can easily read at least 100 screening mammography cases per day.  ProFound AI reduces my stress and worries while reading 3D mammography, and my job satisfaction has improved considerably.”“ProFound AI offers a triple win: it helps radiologists detect more cancers, with fewer unnecessary callbacks, and in less than half the time. This technology is poised to transform breast cancer detection and improve patient lives in the years ahead. I would not send a loved one to a mammography center that didn't have ProFound AI, and there is no way, having experienced the functionality of the software, that I would ever read another tomo study without it.”“In the face of COVID-19, improving accuracy and efficiency for breast cancer screening is now more essential than ever. Using this leading-edge technology, radiologists have the ability to review prior year mammograms and prioritize which patients should not delay breast cancer screening based on the technology’s unique Case Score, which represents a relative level of suspicion for the case containing potentially cancerous findings that may require further workup. It is clinically proven to help radiologists significantly increase their productivity. ProFound AI can also reduce the rate of false positives, which are not only stressful for patients, but also place a significant additional burden on providers. Clinicians using ProFound AI will be very happy they have such a sophisticated tool helping them better position their screening programs’ recovery from this unprecedented global disruption.” Matt Dewey, Chief Information Officer, Wake Radiology“As technology is advancing and becoming a more integral part of our day-to-day workflow, partnering with organizations that provide a clear advantage in AI technologies, like iCAD, has been a critical focus for our facility in recent years. We have done a thorough evaluation of all of the other available AI technologies for breast imaging, but ultimately we found ProFound AI to be the best solution. With its multi-vendor flexibility, ProFound AI seamlessly integrated into our system and clinical workflow.”“After comparing all available options, we felt that iCAD’s technology was simply the best. We needed an AI solution that would allow us to read mammograms from either the Hologic workstation or from the Intelerad® PACS and ProFound AI, which supports multiple output formats, was able to provide that flexibility.”“iCAD is definitely continuing to put resources into improving their technology. Over the last year of using ProFound AI in our clinical practice, we’ve seen the technology advance over time, with noticeable improvements for the latest versions compared to its predecessor. Not only has the algorithm itself improved since we adopted it, the formatting has also improved, making it even better for our radiologists.”Ahuva Grubstain, MD,
Head of Breast Imaging Unit, Department of Imaging, Rabin Medical Center, Hasharon, Israel, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
“We can see the percentage rating of each tumor on the screen, which aids in determining if a suspicious finding needs further workup. The software shortens radiologists’ reading times and enables quick and safe decision-making that helps us avoid unnecessary recalls and tests for patients. iCAD has developed an excellent high-level technology. As a radiologist, I can say that this is the first AI product I have used that enhances my workflow and I trust the results.”
Elena Cauzza, MD,
Radiologist at Radiomedica and xDonna, a mammography and breast diagnosis center in Bellinzona, Switzerland
“Breast cancer is the most common cancer among women; however, the chances of survival are constantly increasing, especially thanks to technological advances in medical imaging that are improving screening performances. ProFound AI is fully in line with this desire to constantly improve radiologists’ abilities to detect breast cancer as early as possible. This is why I chose to install the new generation of the ProFound AI solution in my medical imaging center dedicated to breast imaging, in order to offer my patients the best possible care.”
Emily F. Conant, MD, Division Chief of Breast Imaging at the University of Pennsylvania Medical Center“Our research adds to the growing body of evidence demonstrating the potential value that AI may offer in the clinical setting. Not only may AI algorithms help increase radiologists’ confidence in interpreting DBT studies, it may also help improve reading efficiency. Our retrospective study shows that AI has the potential to correctly identify a third of DBT screening exams as having no malignancy or an extremely low likelihood of malignancy. This AI-triaging could help radiologists determine which cases may need more intensive analysis.”Dr. Axel Gräwingholt, Radiologie am Theater, Paderborn, Germany“ProFound AI as a clinical tool for radiologists has the potential to reduce interval cancer rates by detecting cancers that are already present in the screening round but are perhaps undetected or missed by the readers. Using this technology at the screening level could limit the number of false negatives and help to detect a large proportion of the minimal sign cancers, which could ensure earlier treatment and better chances of recovery for these women.”“This leading-edge technology not only improves radiologist confidence, even while reading complicated datasets, such as those with dense breasts, but also it offers increased sensitivity and specificity, which helps physicians find more cancers, while reducing recall rates for non-cancer cases. As clinicians struggle with the aftermath of COVID19, this technology is uniquely positioned to help address newfound challenges they are beginning to encounter.”“It is currently a prime time for clinicians to leverage the latest technologies, such as ProFound AI, which can help us navigate emerging challenges following this pandemic.”“iCAD’s ProFound AI™ solution has had a significant impact on our workflow. We are able to immediately react if we see something suspicious in a scan alleviating anxiety for our patients. Using the solution will allow us to expand DBT beyond diagnosis because it enables our radiologists to read as many tomosynthesis cases as we currently read with 2D mammography. I consider ProFound AI to be one of the greatest tools in modern radiology.”Dr. Harold Tanenbaum, MD, DABR, MBA, Marine Park Radiology, Brooklyn, NY“iCAD’s ProFound AI for DBT offers a quantum improvement in terms of our efficiency, enabling us to focus on abnormal findings, while reducing the rate of false positives. This is a vital tool for our practice that allows radiologists to zero-in on questionable areas, while reducing reading time and improving our overall confidence in the results.”Neesha Patel, MD,
Director of Breast Imaging and Residency, and Clerkship Academic Director, Kings County Hospital
“ProFound AI provides added confidence – like someone looking over your shoulder- so I know I’m not the only one looking at these images.”
Patrick Toubiana, MD, Radiologist, President and Co-Founder at the C.S.E. Centre Imagerie Médicale Numérique, Paris, France“When breast cancer is diagnosed early, survival after treatment is excellent, over 90% in some countries. At C.S.E., we have been using ProFound AI for 2D Mammography and DBT for several years, during which we have seen iCAD's constant commitment to improve performance in terms of both sensitivity and specificity as new versions are released.”Sally Grady, Director,
Kettering Health Breast Centers, Kettering Health
“We recently updated our breast screening technology at our facility, and ProFound AI is the icing on the cake. We looked at other AI technologies, but have ultimately found them to be like smoke and mirrors compared to ProFound AI. A game-changing technology, ProFound AI has empowered us to offer world-class, personalized patient care. It is light years ahead of other technologies, which simply cannot measure up. I believe that patients without access to ProFound AI are at a disservice. It has helped make our breast screening program one of the best – not only in the state, but also the world.”“ProFound AI is a game changer. Other AI technologies for DBT seem like smoke and mirrors when compared with ProFound AI. It is clearly the most advanced technology of its kind on the market. Improving accuracy and efficiency is key. Every time a patient is called back, that woman assumes she has cancer. Reducing false positives and callbacks is a huge benefit, not only to our patients but to our technologists and radiologists. We only want to call back the women who really need it, and ProFound AI can help our team differentiate that and read mammograms more accurately.”“We felt it was critical to offer this potentially lifesaving technology to all of our patients. We felt offering it to only some of our patients was almost creating a disparity of sorts, and we felt that the value this technology offers was something we wanted to offer to every woman who is screened for breast cancer at one of our centers. Having ProFound AI really helps to set us apart from other facilities in the area; while we upgraded all of our breast screening technology, ProFound AI is truly the icing on the cake.”
Colleen Madden, MD, FACR, Assistant Clinical Professor of Radiology at IUH Ball Memorial Hospital at Indiana University School of Medicine“Overall, this real-world study suggests ProFound AI can help radiologists find more cancers, and with greater accuracy, indicating that this innovative tool can not only enhance clinical performance but also potentially improve outcomes for patients,” said Dr. Madden. “While AI does not eliminate the need for radiologists, it does extend their capabilities considerably, as it greatly assists clinicians in reviewing large DBT datasets and ultimately providing quality care for our patients. We are pleased that this study contributes to the growing body of research that demonstrates the value AI offers in breast cancer screening.”David Harrison, MBT, RT (R) (N), Director of Imaging Services, Wooster Community Hospital“Adopting ProFound AI was a seamless process that offered immediate benefits to our radiologists and patients, and we have gained additional efficiencies since then.”Kathy Schilling,
MD and Radiologist, Boca Raton Regional Hospital
“We recently adopted iCAD’s ProFound AI, which has provided a great deal of assistance in mammography decisions. ProFound AI uses artificial intelligence to rapidly and accurately analyze patients’ digital breast tomosynthesis images, producing a unique and quantifiable Certainty of Finding score for the patients’ overall case.”
Meghan Musser, DO, Medical Director for Breast Imaging at Kettering Health“We have had ProFound AI for about two years now, and the way we utilize it has grown as we’ve learned to trust the technology more. Other AI technologies simply do not deliver the level of performance, speed and accuracy that ProFound AI offers. Additionally, a unique value of ProFound AI is its ability to detect small or subtle lesions, such as invasive lobular cancers (ILCs). I believe that every woman deserves to have access to this technology, as it can be a critical tool in overcoming healthcare disparities. ProFound AI is an integral part of our workflow that is enhancing our ability to personalize breast cancer screening, and I am so happy that this technology is now available to every patient across our network of facilities.”“Other AI technologies simply do not deliver the level of performance, speed and accuracy that ProFound AI offers. Additionally, a unique value of ProFound AI is its ability to detect small or subtle lesions, such as invasive lobular cancers. I believe that every woman deserves to have access to this technology, as it can be a critical tool in overcoming healthcare disparities. ProFound AI is an integral part of our workflow that is enhancing our ability to personalize breast cancer screening, and I am so happy that this technology is now available to every patient across our network of facilities.”“ProFound AI helps to improve clinical confidence while reading mammograms, which then translates into the discussion I have with the patient. ProFound AI is particularly helpful in finding subtle lesions, such as invasive lobular cancers, which tend to be the type of cancers radiologists fear the most, simply because they can be so difficult to detect. In fact, we were hoping to determine whether ProFound AI detected some of the cancers that we had later deemed as interval breast cancers, or cancers that develop between screenings, and in a good portion of those cases, we confirmed ProFound AI did detect something, even if it was subtle, which only further increased our confidence in the technology.”Gabriele Pedicelli, MD, Wooster Community Hospital“Adopting ProFound AI was straightforward. It increases our comfort level knowing that the technology is reading every image, or slice, and it’s reassuring knowing that this technology will help us not miss a cancer. I typically will read the images without ProFound AI first, just to get a gut impression of the case, but when I turn ProFound AI on, it gives me added peace of mind knowing that the technology will alert me to look at certain images more closely.”“ProFound AI significantly reduces the time it takes to review 3D tomo datasets, thus reducing the amount of time needed between patients. The technology allows us to fully harness the advantages our 3D mammography system offers and improves our overall efficiency, which allows us to see more patients throughout the day within the same timeframe.”“Currently, dense breasts are considered a risk factor because dense breast tissue masks cancerous tissue on mammography images. ProFound AI not only helps us to review cases with fatty tissue, we see an even greater benefit for those women with dense breasts. Before ProFound AI, I might have read a case with dense breasts and thought ‘Let’s call them back in 6 months or a year,’ but with ProFound AI, we can more easily tell whether we should be doing another examination or biopsy. In fact, there have been two recent cases with dense breasts in a short period of time where ProFound AI helped us make the decision for a follow up, and they both turned out to be cancers.”“I would certainly recommend ProFound AI to other radiologists and imaging centers. Based on my experience reading mammography, I typically feel comfortable making the call of whether it is negative or positive, but the added confidence of calling something negative is the most significant advantage this technology offers to patients.” Lisa Sheppard, MD, PINK Breast Center“As soon as we implemented ProFound AI, we started using it on all of our DBT breast cancer screenings. It greatly improved our workflow and enabled us to get back to rapid reads and offered the opportunity to provide results for patients in real-time.”“This technology has made a tremendous impact on patient care at PINK Breast Center. It helped to ensure that the biopsies we perform are more likely to be cancer, and we also now have fewer false positives and callbacks. It also helps to improve our confidence while reading DBT, even with complicated cases. For example, when you have a case that’s extra dense or has a lot of nodules or calcifications, ProFound AI allows us to read it with a higher level of confidence and make better decisions for the patients.”“It was very exciting when I learned that ProFound AI for DBT was FDA-cleared. I couldn’t wait to jump on the bandwagon to start using it. We were the first in Northern and Central New Jersey to adopt this technology – it was just another example of our practice striving to bring the best possible technology to enhance our patient care.”“When ProFound AI highlights an area, we know it’s something to investigate. It’s much more selective than other CAD technologies and offers a remarkable improvement in terms of the focus. We know it works because we’re seeing more of our biopsies actually turn out to be cancer. This technology is fabulous, and it really makes a difference. AI coupled with the physician is where medicine is going to go. I don’t think AI could ever replace a physician, but it certainly enhances the physician and ensures a more accurate read for the patient.”“The initial investment in this technology was insignificant compared to the benefits it offers to our patients. There is tremendous value in being able to confidently tell my patients, ‘I read your mammogram today and it is negative, but I also want to reassure you, ProFound AI agrees and found you are negative.’ This technology really helps to put both me and my patients at ease.”

ProFound AI Risk

Per Hall, MD, Professor/Senior Physician, Karolinska Institutet“Our algorithm is designed to provide physicians with information about a woman’s short-term risk of being diagnosed with breast cancer, so that they may further personalize her screening and surveillance plan. This may include screening frequency adjustment, supplemental imaging, genetic testing and/or risk reduction strategies. Ultimately, the goal of this technology is to enhance efficiency for clinicians and improve outcomes for patients through earlier detection.”“This leading-edge algorithm was designed to provide physicians with crucial information about a woman’s short-term risk of being diagnosed with breast cancer, so that they may further personalize her screening and surveillance plan. This may include screening frequency adjustment, supplemental imaging, genetic testing and/or risk reduction strategies. Ultimately, the goal of this technology is to enhance efficiency for clinicians and improve outcomes for patients.”“The ProFound AI Risk model performs better than any other current model. The model is a short-term risk model which is an advantage in the screening setting, builds heavily on analyses of mammograms, is easy and inexpensive to implement and has little requirement of staff and systems to manage the data. Further, the risk model was also tested using other variables, such as lifestyle factors and genetic determinants, which may be added to the iCAD product in the future.”“Models that accurately predict an individual woman’s risk of developing breast cancer are paramount to transitioning from age-based screening to risk-based screening. Most current risk models are population-based and focus on lifetime or long-term risk. Our research using the iCAD AI technology has shown that by simply using the information available in the mammogram images, we can more accurately stratify women based on short-term risk. Understanding short-term risk will open the door to new paradigms in both the prevention and treatment of breast cancer.”“The ProFound AI Risk model is a validated short-term risk model that provides clinically relevant data about patients’ individual risk of developing cancer between screenings. Our study data show that the ProFound AI Risk model offers significantly superior performance compared to any other current model.”Dr. Axel Gräwingholt, Radiologie am Theater, Paderborn, Germany“ProFound AI Risk is a powerful tool that may aid in the detection of interval cancers, or lesions that are detected between routine mammography screenings. In my experience using the technology, I have found it offers valuable insights for clinicians who may be looking to provide a stratified risk assessment for patients, and is easy to use compared to other breast cancer risk models.”“ProFound AI Risk is a powerful tool that may aid in the detection of interval cancers, or lesions that are detected between routine mammography screenings. In my experience using the technology, I have found it offers valuable insights for clinicians who may be looking to provide a stratified risk assessment for patients, and is easy to use compared to other breast cancer risk models.”“This leading-edge algorithm was designed to provide physicians with crucial information about a woman’s short-term risk of being diagnosed with breast cancer, so that they may further personalize her screening and surveillance plan. This may include screening frequency adjustment, supplemental imaging, genetic testing and/or risk reduction strategies. Ultimately, the goal of this technology is to enhance efficiency for clinicians and improve outcomes for patients.”Randy Hicks, MD, MBA., Radiologist, Co-owner & CEO of Regional Medical Imaging“ProFound AI Risk takes personalized breast cancer screening to the next level. It is efficient and easy-to-use. This first-in-kind technology seamlessly integrates into our workflow and offers a next-generation solution to stratify individual risk for our patients on the fly, with greater accuracy than traditionally used, hard to obtain and time-consuming risk models. It provides critical insights based off information garnered from 2D or 3D mammogram images, which helps the RMI team further personalize screening and surveillance plans for our patients.”Patrick Toubiana, MD, Radiologist, President and Co-Founder at the C.S.E. Centre Imagerie Médicale Numérique, Paris, France“We are proud to be the first private medical imaging center in France to benefit from iCAD’s latest solution, ProFound AI Risk. This innovative technology calculates the individual risk of breast cancer, from the analysis of information contained in the mammogram, such as density, texture, asymmetries and patient age, which is a much more precise approach than other risk models currently offered. This new algorithm allows us to identify women who are at higher risk of developing short-term breast cancer, and to personalize our follow-up for these women.”

PowerLook Density Assessment

Paul J. Risk BSc MD FRCPC,
DI Clinical Director/Breast Specialist Radiologist, Bermuda Cancer and Health Centre
“I’m finding mammographic areas of concern in dense breasts that would have otherwise been lost in the Bermuda Triangle!”
Adrea Bennett,
Center for Women Supervisor, Swedish-American Hospital
“Installing PowerLook Density Assessment has helped improve the workflow of our department and also in the education of our patients about the importance of knowing your breast density.”
Angela Fried, MD,
Director of Breast Imaging, SimonMed Imaging
“We have had the AI density breast program for several years now and at the beginning there were some issues with radiologists not agreeing with what the determination was, but it has gotten very accurate, and our techs are able to take that information and plug it into the risk model without having to bother a radiologist to ask what density they should put. We are able to very quickly add that information to our reports and give that information to the patient and their physician to know if they should be coming in for additional screening. It’s something that give patients peace of mind when they have very dense breast tissue or to identify cancer earlier.”
Jason Stiver,
Radiology Department Manager at Punxsutawney Area Hospital
“PowerLook Density Assessment takes all the guess work out of determining breast density. If any other facility wants the most accurate and reliable software for its patients, look no further than PowerLook Density Assessment.”
Randy Hicks, MD, MBA., Radiologist, Co-owner & CEO of Regional Medical Imaging“Radiologist visual density assessment has suboptimal intra- and inter- observer agreement due to its visual, subjective assessment. This inconsistent reporting causes confusion, impacts patient care and derails referring physician and patient confidence. With PowerLook Density Assessment software, clinicians can feel confident in their patients’ density assessment. This solution is easy to integrate and implement, and is the ideal choice for those seeking to accurately automate density assessment and harmonize the patient experience.”

 

© iCAD Inc.  All rights reserved.  iCAD, the iCAD logo, PowerLook, ProFound AI, ProFound, Xoft, the Xoft logo, Axxent, Electronic Brachytherapy System and eBx are trademarks of iCAD, Inc. Reproduction of any of the material contained herein in any format or media without the express written permission of iCAD, Inc. is prohibited.

Facebook icon Twitter icon LinkedIn icon